From: Potential prognosis index for m6A-related mRNA in cholangiocarcinoma
 | Alive (n = 18) | Dead (n = 18) | Total (n = 36) | P-value |
---|---|---|---|---|
Gender | ||||
 Male | 8 (44%) | 9 (50%) | 16 (44%) | 0.9959 |
 Female | 10 (56%) | 9 (50%) | 20 (56%) | |
Age | ||||
 Mean (SD) | 63 (13.4) | 63 (12.7) | 63 (12.8) |  |
 Median [Min, Max] | 68.5 [29, 82] | 65 [31, 81] | 66.5 [29, 82] |  |
 Stages I–II | 15 (83%) | 13 (72%) | 28 (78%) | 0.69 |
 Stages III–IV | 3 (17%) | 5 (28%) | 8 (22%) |